Calendar Syndax Pharmaceuticals, Inc.

Equities

SNDX

US87164F1057

Delayed Nasdaq 03:56:02 2024-04-22 pm EDT 5-day change 1st Jan Change
20.88 USD +0.38% Intraday chart for Syndax Pharmaceuticals, Inc. -3.35% -3.31%

Chart calendar Syndax Pharmaceuticals, Inc.

4ede00.xRcMQCD0Ve8PGOKCYwmKrm7uFRkhtTbuKi2gIMWK5YA.qXBuLBebAas-d9bOGXy-3iixZXRi01StH2_3TrDVjcWuJTwuFrsQmm1qrw~4b03e01ccbc1775716cf371a2a67a382

Upcoming events on Syndax Pharmaceuticals, Inc.

2024-05-05 Q1 2024 Earnings Release (Projected)
2024-05-15 08:30 am Annual General Meeting
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-04 Q4 2024 Earnings Release (Projected)

Past events on Syndax Pharmaceuticals, Inc.

2024-04-17 11:00 am Stifel Virtual Targeted Oncology Days Conference
2024-04-02 American Society of Pediatric Hematology/Oncology Conference
2024-03-12 08:30 am Barclays Global Healthcare Conference
2024-03-04 12:50 pm TD Cowen Health Care Conference - Panel
2024-03-04 09:50 am TD Cowen Health Care Conference
2024-02-27 04:30 pm Q4 2023 Earnings Call
2024-02-27 04:05 pm Q4 2023 Earnings Release
2024-02-21 02:00 pm Citi Oncology Leadership Summit
2024-02-08 10:00 am Guggenheim Healthcare Talks Biotechnology Conference
2024-01-18 01:30 pm B. Riley Securities Oncology Conference - Track 1
2024-01-08 08:15 pm JPMorgan Healthcare Conference
2023-12-12 01:00 pm American Society of Hematology Meeting - Abstract Number: LBA-5
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number : 4950
2023-12-11 10:00 am American Society of Hematology Meeting
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract Number: 2540
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract Number : 2907
2023-12-10 American Society of Hematology Meeting
2023-12-10 05:00 pm American Society of Hematology Meeting - Abstract Number: 1
2023-12-09 American Society of Hematology Meeting
2023-12-09 01:15 pm American Society of Hematology Meeting - Abstract Number : 58

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
1,52
1,50
1.29%
1,52
1,47
3.54%
140
81,4
71.65%
0,00
0,33
-
0,00
0,00
-

31,4

EBITDA
Million USD
Released
Forecast
Spread
-58,2
-57,5
-1.3%
-71,3
-71,7
0.51%
26,9
34,3
-21.62%
-155
-149
-3.75%
-245
-233
-5.05%

-357

EBIT
Million USD
Released
Forecast
Spread
-57,5
-57,8
0.54%
-71,4
-72,5
1.48%
26,2
-21,7
220.66%
-152
-150
-1.33%
-230
-226
-1.93%

-333

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-56,0
-56,1
0.18%
-73,2
-75,2
2.68%
24,9
-72,7
134.3%
-149
-150
0.12%
-209
-207
-1.33%

-325

Net income
Million USD
Released
Forecast
Spread
-56,0
-56,3
0.39%
-77,1
-77,5
0.58%
24,9
-72,7
134.3%
-149
-150
0.36%
-209
-208
-0.58%

-312

EPS
USD
Released
Forecast
Spread
-1,84
-1,87
1.39%
-1,87
-1,81
-3.54%
0,48
-1,41
134.16%
-2,46
-2,48
0.62%
-2,98
-2,94
-1.5%

-3,73

Announcement Date03/03/2008/03/2101/03/2228/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
127
58,7
115.72%
0,00
2,56
-
0,00
1,10
-
0,00
0,60
-
0,00
0,43
-
0,00
0,50
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


5,99


26,0

EBITDA
Million USD
Released
Forecast
Spread
























-81,4
-73,5
-10.71%

-75,6


-77,7


-80,0




EBIT
Million USD
Released
Forecast
Spread
95,7
39,5
142.67%
-36,9
-34,8
-6.03%
-37,7
-36,5
-3.32%
-35,1
-37,7
6.77%
-42,0
-39,6
-6.14%
-46,0
-43,1
-6.83%
-49,7
-54,3
8.47%
-56,4
-59,0
4.52%
-77,9
-73,5
-6.02%

-84,2


-88,6


-86,3


-71,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
96,2
-1,21
8037.13%
-37,2
-37,6
1.19%
-37,6
-38,7
3%
-35,4
-38,7
8.44%
-39,2
-39,9
1.75%
-41,1
-39,8
-3.3%
-44,6
-52,9
15.66%
-51,1
-55,0
7.07%
-72,5
-69,8
-3.77%

-80,3


-84,4


-80,5


-77,9

Net income
Million USD
Released
Forecast
Spread
96,2
-1,21
8037.13%
-37,2
-36,7
-1.2%
-37,6
-38,9
3.45%
-35,4
-38,7
8.48%
-39,2
-41,1
4.59%
-41,1
-40,4
-1.91%
-44,6
-50,8
12.17%
-51,1
-55,9
8.44%
-72,5
-71,5
-1.36%

-79,7


-83,9


-81,0


-64,3

EPS
USD
Released
Forecast
Spread
1,81
-0,03
6133.33%
-0,63
-0,64
1.56%
-0,62
-0,66
5.7%
-0,58
-0,65
10.08%
-0,62
-0,66
5.82%
-0,59
-0,60
1.01%
-0,64
-0,73
12.03%
-0,73
-0,80
8.62%
-1,00
-0,96
-4.41%

-0,98


-1,03


-0,98


-0,77

Announcement Date01/03/2209/05/2208/08/2203/11/2228/02/2308/05/2303/08/2302/11/2327/02/24----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SNDX Stock
  4. Calendar Syndax Pharmaceuticals, Inc.